We've gathered analysts' opinions on BEIGENE, LTD. future price: according to them, price has a max estimate of CNY and a min estimate of View the latest BeiGene Ltd. ADR (BGNE) stock price, news, historical charts, analyst ratings and financial information from WSJ. View today's BeiGene Ltd stock price and latest BGNE news and analysis. Create real-time notifications to follow any changes in the live stock price. The 27 analysts offering price forecasts for BeiGene have a median target of , with a high estimate of and a low estimate of The median. See the latest BeiGene Ltd ADR stock price (BGNE:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Track BeiGene (BGNE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable. The company's ordinary shares, which trade on the Hong Kong Stock Exchange, will be included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong. BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and. Beigene (BGNE) real time stock quotes, news, chart, key statistics and vital financial information with AInvest. BeiGene, Ltd. (lpage-expert.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BeiGene, Ltd. | Nasdaq: BGNE | Nasdaq. RMB Shares begin trading on the STAR Market under the stock code “”, making BeiGene the first triple-listed biotech company on NASDAQ, Hong Kong Stock. Beigene Ltd BGNE:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/11/24 · 52 Week Low Latest Headlines · BeiGene, - Depositary Receipt () (BGNE) Price Target Increased by % to · BeiGene, - Depositary Receipt () (BGNE) Price Target. BeiGene, (BGNE) Stock Price Forecast: AI Forecasts BGNE Stock Price To Be Around $ In A Month (Up %). Complete BeiGene Ltd. ADR stock information by Barron's. View real-time BGNE stock price and news, along with industry-best analysis. Get Beigene Ltd (BGNE.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Earnings per share. Represents the company's profit divided by the outstanding shares of its common stock. , %. EBITDA. Earnings before interest. Find the latest BeiGene, Ltd. (BGNE) stock quote, history, news and other vital information to help you with your stock trading and investing. On which exchange is BeiGene listed, what is the ticker symbol, and when did BeiGene go public? BeiGene's American Depositary Shares are traded under the. Shares Out: M. M = Million B = Billion. DR Program Information. Company name, BeiGene, Ltd. Current Book Status, OPEN. CUSIP, L (Active). Ratio . Stock analysis for BeiGene Ltd (BGNE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. On average, Wall Street analysts predict that Beigene's share price could reach $ by Aug 20, The average Beigene stock price prediction forecasts a. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Stock Information. Analyst Coverage · Stock Chart. Filings & Financials BeiGene. © BeiGene LTD. All Rights Reserved.. By clicking “Accept All. BeiGene (BGNE) reported Q1 earnings per share (EPS) of -$, beating estimates of -$ by %. In the same quarter last year, BeiGene's earnings per.
BGNE stock analysis and financial data, including key statistics and ratios, valuations, historical price and financial performance of BeiGene. Discover real-time BeiGene, Ltd. American Depositary Shares (BGNE) stock prices, quotes, historical data, news, and Insights for informed trading and. Stock Price Forecast. The 7 analysts with month price forecasts for BeiGene stock have an average target of , with a low estimate of and a high. Get the latest updates on BeiGene, Ltd. American Depositary Shares (BGNE) pre market trades, share volumes, and more. Make informed investments with Nasdaq. The Shares began trading today on the Main Board of the Stock Exchange of Hong Kong Limited under the stock code "". The gross proceeds to BeiGene from the.
BeiGene opens flagship US biologics manufacturing and clinical R&D facility, continues global expansion to deliver medicines to more patients around the world. BeiGene Stock Rises on FDA Fast Track Tag for Investigational Cancer Therapy. Seeking AlphaAug 26 ET · BeiGene's BGB Receives U.S. FDA Fast Track.